Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Great Article about Pricing
View:
Post by DavidKingCanada on Nov 01, 2021 12:00pm

Great Article about Pricing

It seems like the two major Players thus far are:

Biogens Aducanumab
Eli Lillys Donanemab

https://www.ipwatchdog.com/2021/10/26/assessing-much-alzheimers-drug-worth/id=139154/
Comment by kalman007 on Nov 01, 2021 5:05pm
So where the hell is PMN?  They' don't even get a small mention and they've been at it for years!  I feel like their deadlines, clinicals, FDA approvals blah blah blah..and other promises (no pun intended) come and go.  The runway seems to be forever.  I get that Rome wasn't built in a day but I question the truth behind the new releases.  I for one have ...more  
Comment by TopBroker on Nov 01, 2021 6:36pm
The problem with the stock split is that this incompetent board will roll you back to oblivion, do another cheap financing and crush the shareholders. Goldstein, Williams, Kirwin, Gregory and Wyman must all be replaced and all of them together have no clue about what it takes to run a successful public Company. Do not give them the right to discretionarily destroy your investment. Don't forget ...more  
Comment by SouthernTierTom on Nov 02, 2021 12:16am
Where is PMN?  How far into the trial are they?  Do they have data yet? Likely why there is no mention...patience bud!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities